Literature DB >> 11824932

Responsibility and cancer disclosure in Japan.

Todd S Elwyn1, Michael D Fetters, Hiroki Sasaki, Tsukasa Tsuda.   

Abstract

In Japan, as in many countries around the world, cancer patients are often not told the truth about their illness. Despite polls showing a majority of those surveyed wish to be told, surveys of physicians indicate only a small percentage will tell, especially when the cancer is advanced or terminal. We interviewed physicians from various specialties with experience managing advanced or terminal cancer patients to investigate their approaches to cancer disclosure. Our analysis reveals physicians divide into two groups: those who usually do not tell (non-tellers) such patients and those who usually do tell (tellers). Non-tellers reported the shock of disclosure inhibits telling patients, families' wishes for non-disclosure cannot be ignored, and most patients themselves do not wish to be told. Tellers asserted disclosure is unavoidable and patients want to be told, few problems result when they tell, and telling has many advantages such as not having to lie to the patient. Despite the experience of non-tellers, most physicians continue to follow the traditional approach, for advanced or terminal cancers. Physicians, as well as families and patients, display an aversion to taking responsibility for the potential risks of disclosure, and this may perpetuate the status quo.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Year:  2002        PMID: 11824932     DOI: 10.1016/s0277-9536(01)00028-4

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  21 in total

Review 1.  Reluctance to disclose difficult diagnoses: a narrative review comparing communication by psychiatrists and oncologists.

Authors:  Alex J Mitchell
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.603

Review 2.  Cultural aspects of communication in cancer care.

Authors:  Antonella Surbone
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

3.  Perceptions of Cancer Status Disclosure in Lebanon.

Authors:  Sally Temraz; Miza Salim Hammoud; Ahmad Saleh; Maya Charafeddine; Deborah Mukherji; Ali Shamseddine
Journal:  J Cancer Educ       Date:  2019-10       Impact factor: 2.037

4.  Factors influencing the attitudes of Chinese cancer patients and their families toward the disclosure of a cancer diagnosis.

Authors:  Wenwen Sun; Zhehai Wang; Shu Fang; Minmin Li
Journal:  J Cancer Educ       Date:  2015-03       Impact factor: 2.037

5.  Construct validity of the EORTC quality of life questionnaire information module.

Authors:  Susanne Singer; Philipp M Engelberg; Gregor Weißflog; Susanne Kuhnt; Jochen Ernst
Journal:  Qual Life Res       Date:  2012-01-17       Impact factor: 4.147

6.  The Relation between Awareness of Cancer Diagnosis and Spiritual Health among Cancer Patients.

Authors:  Shima Sadat Aghahosseini; Azad Rahmani; Farahnaz Abdollahzadeh; Iraj Asvadi Kermani
Journal:  J Caring Sci       Date:  2012-05-27

7.  A survey of disclosure of diagnosis to patients with glioma in Japan.

Authors:  Fukuko Yamamoto; Naoya Hashimoto; Naoki Kagawa; Yoshiko Okita; Yasuyoshi Chiba; Noriyuki Kijima; Manabu Kinoshita; Kikuko Yoshizu; Yasunori Fujimoto; Kei Hirai; Toshiki Yoshimine
Journal:  Int J Clin Oncol       Date:  2010-12-08       Impact factor: 3.402

8.  Japanese Cancer Survivors' Awareness of and Participation in Support Groups.

Authors:  Yutaka Hatano; Sachiko Mitsuki; Toyoshi Hosokawa; Kenji Fukui
Journal:  J Cancer Educ       Date:  2018-02       Impact factor: 2.037

9.  Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell?

Authors:  H Miyata; M Takahashi; T Saito; H Tachimori; I Kai
Journal:  J Med Ethics       Date:  2005-08       Impact factor: 2.903

10.  Revealing a cancer diagnosis to patients: attitudes of patients, families, friends, nurses, and physicians in Lebanon-results of a cross-sectional study.

Authors:  F Farhat; A Othman; G El Baba; J Kattan
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.